Stada And Calliditas Celebrate European Nod For Budesonide Hybrid
As Four Generics Also Endorsed By EMA’s CHMP At May Meeting
The EMA’s CHMP has issued a positive opinion for the Kinpeygo budesonide 4mg modified-release hard capsules hybrid medicine developed by Calliditas that will be marketed in Europe by Stada. Meanwhile, four generics from Accord, Fresenius Kabi, Gedeon Richter and Sun have also been endorsed by the committee.
